Methionine

Methionine

SCHEMBL3182763

CSCC[C@H](N)C(=O)O.Cc1cc(=O)oc2cc(N)ccc12

nearest known ligand 0.60

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.60
KDM4E B2RXH2 7/20 0.60
HPGD P15428 5/20 0.60
GLA P06280 5/20 0.60
GAA P10253 5/20 0.60
CA9 Q16790 5/20 0.60
HSD17B10 Q99714 4/20 0.60
CA12 O43570 4/20 0.60
CA1 P00915 4/20 0.60
CASP1 P29466 2/20 0.60
CASP7 P55210 2/20 0.60
LMNA P02545 2/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
CYP1A2 P05177 1/20 0.44
CYP2C9 P11712 1/20 0.44
AKR1B1 P15121 1/20 0.44
UGT1A1 P22309 1/20 0.44
MAOB P27338 1/20 0.44
KDR P35968 1/20 0.44
HSD17B3 P37058 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Racemethionine SCHEMBL27913718 1.00 ALDH1A1 (0.60) ALDH1A1KDM4EHPGDGLAGAA
Methionine SCHEMBL4192137 0.98 ALDH1A1 (0.57) ALDH1A1KDM4EHPGDGLAGAA
Racemethionine SCHEMBL28910330 0.94 ALDH1A1 (0.53) ALDH1A1KDM4EHPGDGLAGAA
D-Glutamate SCHEMBL28805166 0.86 ALDH1A1 (0.63) ALDH1A1KDM4EHPGDGLAGAA
Glutamine SCHEMBL26967759 0.85 ALDH1A1 (0.61) ALDH1A1KDM4EHPGDGLAGAA
Ornithine SCHEMBL6427980 0.85 ALDH1A1 (0.61) ALDH1A1KDM4EHPGDGLAGAA
Glutamine SCHEMBL6427499 0.85 ALDH1A1 (0.61) ALDH1A1KDM4EHPGDGLAGAA
Serine SCHEMBL6428011 0.85 ALDH1A1 (0.68) ALDH1A1KDM4EHPGDGLAGAA
Serine SCHEMBL27896307 0.85 ALDH1A1 (0.68) ALDH1A1KDM4EHPGDGLAGAA
Phenylalanine SCHEMBL7214651 0.84 IGLV6-57 (0.43) ALDH1A1KDM4EHPGDGLAGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 78 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1352083-B1 COMPOSITIONS AND METHODS FOR DETECTING TARGET MICROORGANISMS IN A SAMPLE BIOCONTROL SYSTEMS INC (US) 2005-10-26 EP claimed
US-20040077031-A1 Novel methionine aminopeptidase-2 and uses thereof ABBOTT LABORATORIES 2004-04-22 US claimed
CN-120082639-A Large-scale parallel sequencing using unlabeled nucleotides 深圳华大智造科技股份有限公司 2025-06-03 CN disclosed
CN-113272448-B Large-scale parallel sequencing using unlabeled nucleotides 深圳华大智造科技股份有限公司 2025-02-07 CN disclosed
EP-3589743-B1 RECOVERY MEDIUM FOR DETECTION OF MICROORGANISMS BY FLUORESCENCE AMERICAN STERILIZER CO (US) 2023-06-21 EP disclosed
CN-116194158-A Biological indicator comprising genetically modified test microorganism 3M创新有限公司 2023-05-30 CN disclosed
CN-115461468-A Biological indicator with test microorganisms encapsulated by wax composition 3M创新有限公司 2022-12-09 CN disclosed
CN-115315522-A Fixed pH indicator for biological indicator growth indication 3M创新有限公司 2022-11-08 CN disclosed
CN-114981399-A Self-contained biological indicator with salt compound 3M创新有限公司 2022-08-30 CN disclosed
US-10301632-B2 Biological indicator AMERICAN STERILIZER COMPANY (US) 2019-05-28 US disclosed
US-10301631-B2 Biological indicator AMERICAN STERILIZER COMPANY (US) 2019-05-28 US disclosed
WO-2002005804-A1 COMPOUNDS AND METHODS SMITHKLINE BEECHAM CORPORATION (US) 2002-01-24 WO disclosed
WO-2001078723-A1 COMPOUNDS AND METHODS SMITHKLINE BEECHAM CORPORATION (US) 2001-10-25 WO disclosed
WO-2001036404-A1 COMPOUNDS AND METHODS SMITHKLINE BEECHAM CORPORATION (US) 2001-05-25 WO disclosed
WO-2001024796-A1 1,2,4-TRIAZOLE DERIVATIVES, COMPOSITION, PROCESS OF MAKING AND METHODS OF USE SMITHKLINE BEECHAM CORPORATION (US) 2001-04-12 WO disclosed
EP-0516814-B1 METHOD AND COMPOSITION FOR DETERMINING ANTIMICROBIAL SUSCEPTIBILITY OF THE MAJORITY OF CLINICALLY SIGNIFICANT GRAM POSITIVE ORGANISMS DADE MICROSCAN INC (US) 1996-09-04 EP disclosed
US-5457030-A Using fluorogenic substrates to detect bacterial growth MICROSCAN, INC. (US) 1995-10-10 US disclosed
EP-0516814-A4 METHOD AND COMPOSITION FOR DETERMINING ANTIMICROBIAL SUSCEPTIBILITY OF THE MAJORITY OF CLINICALLY SIGNIFICANT GRAM POSITIVE ORGANISMS BAXTER DIAGNOSTICS INC (US) 1994-06-01 EP disclosed
EP-0516814-A1 METHOD AND COMPOSITION FOR DETERMINING ANTIMICROBIAL SUSCEPTIBILITY OF THE MAJORITY OF CLINICALLY SIGNIFICANT GRAM POSITIVE ORGANISMS. BAXTER DIAGNOSTICS INC (US) 1992-12-09 EP disclosed
WO-1992012257-A1 METHOD AND COMPOSITION FOR DETERMINING ANTIMICROBIAL SUSCEPTIBILITY OF THE MAJORITY OF CLINICALLY SIGNIFICANT GRAM POSITIVE ORGANISMS BAXTER DIAGNOSTICS INC. (US) 1992-07-23 WO disclosed